ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigms Two Arthritis Phase 2 Clinical Trials on Schedule
Published: 23/11/17, 08:27am (AEST)•4 pages